Journal of Environmental Pathology, Toxicology and Oncology

ISSN for PRINT: 0731-8898

For Online Access

Best Paper Award Selection - Editorial Board Site

2003, Volume22

Issue 4

82 pages

DOI: 10.1615/JEnvPathToxOncol.v22.i4

Issue price - $160.00

Martha Susana Bianchi
Laboratorio de Citogenética y Mutagénesis, Instituto Multidisciplinario de Biologia Celular (IMBICE, CCT-La Plata-CONICET-CICPBA); Miembro de la Carrera del Investigador Cientifico del CONICET, Argentina

Alejandro Daniel Bolzan
Laboratorio de Citogenética y Mutagénesis, Instituto Multidisciplinario de Biologia Celular (IMBICE, CCT-La Plata-CONICET-CICPBA); Miembro de la Carrera del Investigador Cientifico del CONICET, Argentina

We investigated the clastogenic effects of the methylating agent streptozotocin (STZ) on two human colon cancer cell lines. COLO320DM and COLO320HSR are cell lines derived from a human neuroendocrine colon carcinoma. STZ produced a dose-dependent increase in the frequency of chromosomal aberrations in both cell lines (p < 0.05) and induced fragmentation and/or pulverization of COLO320DM and COLO320HSR chromosomes. This effect was dose and time dependent. Severe chromosome damage was also found in cells that had progressed beyond the first metaphase, and a higher percentage of metaphases showing pulverized chromosomes were found in cells after the second than after the first division. This seems to indicate that STZ has a persistent and delayed clastogenic effect on COLO320DM and COLO320HSR cells. In addition, STZ produced a marked depression of the mitotic index in both cell lines. These results demonstrate that human colon cancer cell lines COLO320DM and COLO320HSR are highly sensitive to STZ, and suggest that this antibiotic has a good potential as a chemotherapeutic agent for colon cancer.

DOI: 10.1615/JEnvPathToxOncol.v22.i4.20 Download article, 6 pages

Article price - $35.00

<< Previous article   Next article >>